ATE194911T1 - Anwendung von selegilin in tiermedizin - Google Patents

Anwendung von selegilin in tiermedizin

Info

Publication number: ATE194911T1
Authority: AT; Austria
Prior art keywords: selegiline; application; veterinary medicine; cats; dogs
Prior art date: 1993-05-04

Application number

AT94400949T

Other languages

English (en)

Inventor

Marie Sophie Filhol

Thierry Pobel

Original Assignee

Ceva Sante Animale

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-05-04

Filing date

1994-05-02

Publication date

2000-08-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26230300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE194911(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-05-04 Priority claimed from FR9305305A external-priority patent/FR2704756B1/fr

1993-12-22 Priority claimed from FR9315495A external-priority patent/FR2713930B3/fr

1994-05-02 Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale

2000-08-15 Application granted granted Critical

2000-08-15 Publication of ATE194911T1 publication Critical patent/ATE194911T1/de

Links

MEZLKOACVSPNER-GFCCVEGCSA-N selegiline Chemical compound C#CCN(C)[C@H](C)CC1=CC=CC=C1 MEZLKOACVSPNER-GFCCVEGCSA-N 0.000 title abstract 2
229960003946 selegiline Drugs 0.000 title abstract 2
206010000117 Abnormal behaviour Diseases 0.000 abstract 1
241000282472 Canis lupus familiaris Species 0.000 abstract 1
241000282326 Felis catus Species 0.000 abstract 1
206010027940 Mood altered Diseases 0.000 abstract 1
230000007510 mood change Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT94400949T 1993-05-04 1994-05-02 Anwendung von selegilin in tiermedizin ATE194911T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9305305A FR2704756B1 (fr)	1993-05-04	1993-05-04	Utilisation de la sélégiline en médecine vétérinaire.
FR9315495A FR2713930B3 (fr)	1993-12-22	1993-12-22	Utilisation de la Sélégiline en médecine vétérinaire.

Publications (1)

Publication Number	Publication Date
ATE194911T1 true ATE194911T1 (de)	2000-08-15

Family

ID=26230300

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94400949T ATE194911T1 (de)	1993-05-04	1994-05-02	Anwendung von selegilin in tiermedizin

Country Status (9)

Country	Link
US (1)	US5547995B1 (de)
EP (1)	EP0623344B1 (de)
AT (1)	ATE194911T1 (de)
CA (1)	CA2122780C (de)
DE (1)	DE69425345T2 (de)
DK (1)	DK0623344T3 (de)
ES (1)	ES2149850T3 (de)
GR (1)	GR3034661T3 (de)
PT (1)	PT623344E (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6262111B1 (en)	1997-05-21	2001-07-17	Sloan-Kettering Institute For Cancer Research	Method for increasing the concentration of ascorbic acid in brain tissues of a subject
JP2002513383A (ja)	1997-05-21	2002-05-08	スローン−ケタリング・インスティテュート・フォー・キャンサー・リサーチ	患者の脳組織でのアスコルビン酸の濃度を増加させる方法
SK252004A3 (sk) *	2001-07-20	2005-03-04	Pfizer Products Inc.	Použitie antagonistov receptora NK-1 na výrobu liečiva na liečenie abnormálneho úzkostného správania domácich zvierat a spôsob screeningu skúšanej zlúčeniny s cieľom stanoviť anxiolytickú účinnosť u psov
JP2007504832A (ja) *	2003-09-10	2007-03-08	ヒルズ・ペット・ニュートリシャン・インコーポレーテッド	飼料用オレアミド含有組成物
FR2884421B1 (fr)	2005-04-15	2007-08-10	Virbac Sa	Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU197510B (en) *	1986-12-19	1989-04-28	Chinoin Gyogyszer Es Vegyeszet	Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick
HU208484B (en) *	1988-08-17	1993-11-29	Chinoin Gyogyszer Es Vegyeszet	Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
GB9011767D0 (en) *	1990-05-25	1990-07-18	Britannia Pharmaceuticals Ltd	Pharmaceutical compositions
US5192808A (en) *	1990-08-31	1993-03-09	Deprenyl Animal Health, Inc.	Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
CA2039194C (en) *	1990-08-31	1997-01-28	Norton W. Milgram	Uses of l-deprenyl and compositions for same
US5169868A (en) *	1991-03-01	1992-12-08	University Of Saskatchewan	Aliphatic propargylamines as specific mao-b inhibitors
EP1413299A3 (de) *	1991-04-04	2004-05-06	The University Of Toronto Innovations Foundation	Verwendung von Deprenyl Analoga zur Unterhaltung,Verhinderung von Verlust oder Zurückgewinnung von Nervenzellefunktion

1994
- 1994-05-02 ES ES94400949T patent/ES2149850T3/es not_active Expired - Lifetime
- 1994-05-02 AT AT94400949T patent/ATE194911T1/de not_active IP Right Cessation
- 1994-05-02 EP EP94400949A patent/EP0623344B1/de not_active Expired - Lifetime
- 1994-05-02 PT PT94400949T patent/PT623344E/pt unknown
- 1994-05-02 US US08235965 patent/US5547995B1/en not_active Expired - Lifetime
- 1994-05-02 DE DE69425345T patent/DE69425345T2/de not_active Expired - Fee Related
- 1994-05-02 DK DK94400949T patent/DK0623344T3/da active
- 1994-05-03 CA CA002122780A patent/CA2122780C/fr not_active Expired - Fee Related
2000
- 2000-10-23 GR GR20000402351T patent/GR3034661T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
US5547995B1 (en)	1998-01-27
GR3034661T3 (en)	2001-01-31
PT623344E (pt)	2000-12-29
ES2149850T3 (es)	2000-11-16
EP0623344B1 (de)	2000-07-26
DE69425345T2 (de)	2001-03-01
DK0623344T3 (da)	2000-12-18
CA2122780C (fr)	2004-01-20
DE69425345D1 (de)	2000-08-31
CA2122780A1 (fr)	1994-11-05
EP0623344A1 (de)	1994-11-09
US5547995A (en)	1996-08-20

Similar Documents

Publication	Publication Date	Title
PT93333A (pt)	1990-11-07	Processo de preparacao de uma composicao biocida sinergica e de tratamento usando a referida composicao
DE69230046D1 (de)	1999-10-28	2-Bromomelatonin zur Behandlung von Schlafstörungen
BR9502707A (pt)	1996-06-04	Composto composição farmacêutica e método para o tratamento de uma afecção
DE69127175D1 (de)	1997-09-11	Antisens-Oligonukleotide zur Behandlung von Krebs
ATE411026T1 (de)	2008-10-15	Mittel zur behandlung der alzheimer-krankheit
DE69521994D1 (de)	2001-09-06	Zusammensetzungen welche dna zerstoerende agentien und p53 enthalten
ID26956A (id)	2001-02-22	Pencegahan raf kinase menggunakan simetris dan nonsimetris yang digantikan diphenil urea
DE60031396D1 (de)	2006-11-30	Zubereitung zur behandlung von einer neurologischen erkrankung
DE58902094D1 (de)	1992-10-01	Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
DE69528710D1 (de)	2002-12-05	2-substituierte 1,2,5-thiadiazolidin-3-on-1,1-dioxiden, zusammensetzung und deren verwendung
BR1100384A (pt)	1999-08-31	Composto e formulação farmacêutica
PT88275A (pt)	1989-06-30	Processo para a preparacao de composicoes farmaceuticas contendo 5-amino ou amino substituido-1,2,3-triazois uteis como agentes antiproliferativos
DE69405919D1 (de)	1997-11-06	Zusammensetzungen zur Behandlung von Keratinfasern
ATE90181T1 (de)	1993-06-15	Verwendung von pankreatin enthaltendem futter oder praemix fuer rennpferde und rennkamele.
DE3854121D1 (de)	1995-08-10	Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE194911T1 (de)	2000-08-15	Anwendung von selegilin in tiermedizin
ATE107859T1 (de)	1994-07-15	Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
DE69431199D1 (de)	2002-09-26	Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
ES2096727T5 (es)	2001-07-01	Productos cosmeticos y farmaceuticos que contienen extensinas.
ATE239470T1 (de)	2003-05-15	Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen
DE68909465D1 (de)	1993-11-04	Behandlung von pferdeviehbestand.
ES2066096T3 (es)	1995-03-01	4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
BR9007874A (pt)	1992-09-15	Processo para o tratamento posterior de tenso-ativos anfoteros ou zwitterionicos
ATE25969T1 (de)	1987-04-15	1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
ES2150418T3 (es)	2000-12-01	Composiciones farmaceuticas que comprenden calcitonina.

Legal Events

Date	Code	Title	Description
2001-01-15	UEP	Publication of translation of european patent specification
2011-02-15	REN	Ceased due to non-payment of the annual fee